Earn up to 1.5 CME / ANCC Credits
This activity is provided by GHAPP, with independent educational grant support from Novo Nordisk.
Educational Objectives
After completing this module, participants will be able to:
- Describe current screening, diagnosis, and management options for CLD and GI disorders.
- Apply optimal treatment strategies in practice.
- Compare and contrast available treatment modalities across disease states.
Course Content: What You’ll Learn in This CME Module
This program is structured into three focused sections, blending clinical updates with practical strategies to support your work in gastroenterology and hepatology. Each section is designed to give you actionable insights you can apply right away.
1
Steatotic Liver Disease (SLD) & MASH Managements
- New terminology and classification (MASLD, MASH, ALD, MetALD)
- Risk stratification & staging
- Non-invasive testing (VCTE, ELF).
- Lifestyle modification strategies.
2
Pharmacological Management of MASH
- FDA-approved therapies: Resmetirom & Semaglutide
- Efficacy and safety data from Phase 3 trials.
- Practical treatment algorithms.
3
Irritable Bowel Syndrome (IBS) Management
- Pathophysiology & Rome IV Criteria
- Evidence-based dietary and pharmacological approaches
- IBS-C, IBS-D, and global management strategies.
Claim Your Credit
- Watch the module
- Complete post-test & evaluation
- Download your CME certificate.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the ANCC and AAPA.
Earn up to 1.5 CME / ANCC Credits
